Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
Pushing the Right Buttons
Improving Efficacy of Therapeutic DNA Vectors
Organs-on-Chips Take Flight
Initiative to Use Technology Aboard International Space Station Set to Begin
Another "CRISPR Calamity"? U.K. Team Reports CRISPR-Induced Gene Rearrangements
New Findings Call the Precision of CRISPR-Cas9 Gene Editing into Question
Mats Boren, Ph.D.
Mats Borén, Ph.D., works as head of development at Denator.
More GEN Content From This Contributor
- Tutorials: Stabilization Method for Biological Samples
- Tutorials: Improving Molecular Distribution Analysis
- Columns: The 11 Golden Rules of Working with Proteomic Samples
- Tutorials: Improved Metabolomic Studies